Industry Verticals »

All Categories

Insights »

About TMR »

Inhalation and Nasal Spray Generic Drugs Market

Inhalation and Nasal Spray Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global inhalation and nasal spray generic drugs market for the historical period 2017–2018 and forecast period 2019–2027, increasing prevalence of asthma and COPD disorders, and burgeoning demand for cost-effective generic drugs are projected to drive the global inhalation and nasal spray generic drugs market during the forecast period
  • According to the report, the global inhalation and nasal spray generic drugs market was valued at US$ 27.5 Bn in 2018 and is anticipated to expand at a CAGR of 4.80% from 2019 to 2027
fa global inhalation nasal spray generic drugs marke

To know the scope of our report Get a Sample on Inhalation and Nasal Spray Generic Drugs Market

Rising prevalence of asthma and COPD Disorders: Key Drivers

  • Asthma and chronic obstructive pulmonary disease (COPD) are considered serious health problems. These affect a large proportion of the global population. Smoking, tobacco use, and air pollution are few of the risk factors associated with asthma and COPD. According to the American Lung Association, smoking is the primary risk factor for COPD and approximately 80% of COPD-related deaths are caused by smoking.
  • According to Global Burden of Disease Study 2015, asthma and COPD were the most prevalent chronic respiratory disease, affecting over 360 and 175 million people in 2015, respectively.
  • Prevalence of asthma and COPD is increasing in developed countries due to modernized lifestyle. On the other hand, air pollution and high rate of smoking have led to higher prevalence of serious respiratory diseases in developing countries.
  • Increase in the geriatric population suffering from COPD and asthma is also expected to accelerate the growth of the inhalation and nasal spray generic drugs market

Get a glimpse of the in-depth analysis through our Report Brochure
 

Stringent Regulations for Generic Drugs to Hamper Market

  • With the availability of growing number of low-cost generic inhalation and nasal spray drugs across the globe, various regulatory bodies have opted for stringent norms in order to focus on quality. Regulators in developing regions such as Brazil, Mexico, and Russia have changed their regulatory guidelines pertaining to the sale of generic drugs. This change in regulation norms has led to considerable delays in approval processes, thereby launch of generic drugs in these markets
  • Furthermore, the new regulatory laws in Russia mandate clinical trials for generic products as well, thereby creating hurdles for various pharmaceutical companies operating in the region. Similarly, the Drugs Controller General of India, a domestic drug regulatory body, constituted several new drug advisory committees to oversee and check clinical trials, new drug approval processes, etc.
  • Therefore, stringent and strict regulatory norms put up by various developing countries would lead to sluggish growth of the inhalation and nasal spray generic drugs market.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Inhalation and nasal spray generic drugs Market: Competitive Landscape

  • This report profiles major players in the global inhalation and nasal spray generic drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global inhalation and nasal spray generic drugs market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global inhalation and nasal spray generic drugs market are
    • Allergan plc
    • Beximco Pharmaceuticals Ltd
    • Cipla Limited
    • Mylan N.V.
    • Nephron Pharmaceuticals Corporation
    • Sun Pharmaceutical Industries Ltd.
    • Hikma Pharmaceuticals PLC
    • Sandoz International GmbH (a Novartis Division)
    • Perrigo Company plc
    • Catalent Pharma Solutions
    • Teva Pharmaceutical Industries Ltd.

Global Inhalation and nasal spray generic drugs Market: Key Developments

Key players in the global inhalation and nasal spray generic drugs market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global inhalation and nasal spray generic drugs market. A few expansion strategies adopted by players operating in the global inhalation and nasal spray generic drugs market are:

  • In February 2020, Perrigo Company and Catalent Pharma Solutions announced the attainment of abbreviated new drug application (ANDA) approval from the U.S. FDA for the generic version of ProAir HFA. ProAir HFA is a medication for the treatment and prevention of reversible obstructive airway disease, and bronchospasm. 
  • In July 2015, Hikma Pharmaceuticals acquired Roxane Laboratories Inc. and Boehringer Ingelheim Roxane Inc., from Boehringer Ingelheim. Roxane was one of the leading U.S. specialty generics company. This acquisition enabled Hikma to strengthen its position in the U.S. generics market.

The report on the global inhalation and nasal spray generic drugs market discussed individual strategies, followed by company profiles of manufacturers of inhalation and nasal spray generic drugs. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global inhalation and nasal spray generic drugs market.

Global Inhalation & Nasal Spray Generic Drugs Market - Segmentation

Drug Class

Corticosteroids

  • Fluticasone
  • Budesonide
  • Beclomethasone
  • Flunisolide
  • Others

Bronchodilators

  • Albuterol
  • Epinephrine
  • Others

Antihistamines

  • Combinations
  • Salmeterol/Fluticasone
  • Formoterol/Budesonide
  • Azelastine/Benzalkonium Chloride
  • Others

Decongestant Sprays

  • Phenylephrine Hydrochloride
  • Oxymetazoline Hydrochloride

Indication

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Allergic Rhinitis

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of inhalation and nasal spray generic drugs market?

Inhalation and nasal spray generic drugs market to be worth US$ 42,256.02 mn by 2027

What is the anticipated CAGR of the inhalation and nasal spray generic drugs market in the forecast period?

Inhalation and nasal spray generic drugs market is anticipated to expand at a CAGR of 4.80% from 2019 to 2027

What are the key driving factors for the growth of the inhalation and nasal spray generic drugs market?

Inhalation and nasal spray generic drugs market is driven by increasing prevalence of asthma and COPD disorders

Which is the rising prominent segment in the inhalation and nasal spray generic drugs market?

The asthma segment dominated the global inhalation and nasal spray generic drugs market and the trend is projected to continue during the forecast period

Who are the key players in the inhalation and nasal spray generic drugs market?

Key players in the global inhalation and nasal spray generic drugs market include Allergan plc, Beximco Pharmaceuticals Ltd, Cipla Limited, Mylan N.V., Nephron Pharmaceuticals Corporation

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Inhalation & Nasal Spray Generic Drugs Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Drug Class Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Regulatory Scenario, by Region/Globally

        5.2. Patient Pool Analysis, by Medical Indication

    6. Global Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast, by Drug Class

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Inhalation & Nasal Spray Generic Drugs Market Value Forecast, by Drug Class, 2017–2027

            6.2.1. Corticosteroids

                6.2.1.1. Fluticasone

                6.2.1.2. Budesonide

                6.2.1.3. Beclomethasone

                6.2.1.4. Flunisolide

                6.2.1.5. Others

            6.2.2. Bronchodilators

                6.2.2.1. Albuterol

                6.2.2.2. Epinephrine

                6.2.2.3. Others

            6.2.3. Antihistamines

            6.2.4. Combinations

                6.2.4.1. Salmeterol/Fluticasone

                6.2.4.2. Formoterol/Budesonide

                6.2.4.3. Azelastine/Benzalkonium Chloride

                6.2.4.4. Others

            6.2.5. Decongestant Sprays

                6.2.5.1. Phenylephrine Hydrochloride

                6.2.5.2. Oxymetazoline Hydrochloride

        6.3. Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class

    7. Global Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast, by Indication

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Inhalation & Nasal Spray Generic Drugs Market Value Forecast, by Indication, 2017–2027

            7.2.1. Asthma

            7.2.2. Chronic Obstructive Pulmonary Disease (COPD)

            7.2.3. Allergic Rhinitis

            7.2.4. Others

        7.3. Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication

    8. Global Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Inhalation & Nasal Spray Generic Drugs Market Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Region

    9. North America Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

            9.2.1. Corticosteroids

                9.2.1.1. Fluticasone

                9.2.1.2. Budesonide

                9.2.1.3. Beclomethasone

                9.2.1.4. Flunisolide

                9.2.1.5. Others

            9.2.2. Bronchodilators

                9.2.2.1. Albuterol

                9.2.2.2. Epinephrine

                9.2.2.3. Others

            9.2.3. Antihistamines

            9.2.4. Combinations

                9.2.4.1. Salmeterol/Fluticasone

                9.2.4.2. Formoterol/Budesonide

                9.2.4.3. Azelastine/Benzalkonium Chloride

                9.2.4.4. Others

            9.2.5. Decongestant Sprays

                9.2.5.1. Phenylephrine Hydrochloride

                9.2.5.2. Oxymetazoline Hydrochloride

        9.3. North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

            9.3.1. Asthma

            9.3.2. Chronic Obstructive Pulmonary Disease (COPD)

            9.3.3. Allergic Rhinitis

            9.3.4. Others

        9.4. North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

            9.5.1. By Drug Class

            9.5.2. By Indication

            9.5.3. By Country

    10. Europe Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

            10.2.1. Corticosteroids

                10.2.1.1. Fluticasone

                10.2.1.2. Budesonide

                10.2.1.3. Beclomethasone

                10.2.1.4. Flunisolide

                10.2.1.5. Others

            10.2.2. Bronchodilators

                10.2.2.1. Albuterol

                10.2.2.2. Epinephrine

                10.2.2.3. Others

            10.2.3. Antihistamines

            10.2.4. Combinations

                10.2.4.1. Salmeterol/Fluticasone

                10.2.4.2. Formoterol/Budesonide

                10.2.4.3. Azelastine/Benzalkonium Chloride

                10.2.4.4. Others

            10.2.5. Decongestant Sprays

                10.2.5.1. Phenylephrine Hydrochloride

                10.2.5.2. Oxymetazoline Hydrochloride

        10.3. Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

            10.3.1. Asthma

            10.3.2. Chronic Obstructive Pulmonary Disease (COPD)

            10.3.3. Allergic Rhinitis

            10.3.4. Others

        10.4. Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

            10.4.1. U.K.

            10.4.2. Germany

            10.4.3. France

            10.4.4. Italy

            10.4.5. Spain

            10.4.6. Rest of Europe

        10.5. Europe Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

            10.5.1. By Drug Class

            10.5.2. By Indication

            10.5.3. By Country/Sub-region

    11. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

            11.2.1. Corticosteroids

                11.2.1.1. Fluticasone

                11.2.1.2. Budesonide

                11.2.1.3. Beclomethasone

                11.2.1.4. Flunisolide

                11.2.1.5. Others

            11.2.2. Bronchodilators

                11.2.2.1. Albuterol

                11.2.2.2. Epinephrine

                11.2.2.3. Others

            11.2.3. Antihistamines

            11.2.4. Combinations

                11.2.4.1. Salmeterol/Fluticasone

                11.2.4.2. Formoterol/Budesonide

                11.2.4.3. Azelastine/Benzalkonium Chloride

                11.2.4.4. Others

            11.2.5. Decongestant Sprays

                11.2.5.1. Phenylephrine Hydrochloride

                11.2.5.2. Oxymetazoline Hydrochloride

        11.3. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

            11.3.1. Asthma

            11.3.2. Chronic Obstructive Pulmonary Disease (COPD)

            11.3.3. Allergic Rhinitis

            11.3.4. Others

        11.4. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific 

        11.5. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

            11.5.1. By Drug Class

            11.5.2. By Indication

            11.5.3. By Country/Sub-region

    12. Latin America Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

            12.2.1. Corticosteroids

                12.2.1.1. Fluticasone

                12.2.1.2. Budesonide

                12.2.1.3. Beclomethasone

                12.2.1.4. Flunisolide

                12.2.1.5. Others

            12.2.2. Bronchodilators

                12.2.2.1. Albuterol

                12.2.2.2. Epinephrine

                12.2.2.3. Others

            12.2.3. Antihistamines

            12.2.4. Combinations

                12.2.4.1. Salmeterol/Fluticasone

                12.2.4.2. Formoterol/Budesonide

                12.2.4.3. Azelastine/Benzalkonium Chloride

                12.2.4.4. Others

            12.2.5. Decongestant Sprays

                12.2.5.1. Phenylephrine Hydrochloride

                12.2.5.2. Oxymetazoline Hydrochloride

        12.3. Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

            12.3.1. Asthma

            12.3.2. Chronic Obstructive Pulmonary Disease (COPD)

            12.3.3. Allergic Rhinitis

            12.3.4. Others

        12.4. Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

            12.4.1. Brazil 

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Latin America Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

            12.5.1. By Drug Class

            12.5.2. By Indication

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

            13.2.1. Corticosteroids

                13.2.1.1. Fluticasone

                13.2.1.2. Budesonide

                13.2.1.3. Beclomethasone

                13.2.1.4. Flunisolide

                13.2.1.5. Others

            13.2.2. Bronchodilators

                13.2.2.1. Albuterol

                13.2.2.2. Epinephrine

                13.2.2.3. Others

            13.2.3. Antihistamines

            13.2.4. Combinations

                13.2.4.1. Salmeterol/Fluticasone

                13.2.4.2. Formoterol/Budesonide

                13.2.4.3. Azelastine/Benzalkonium Chloride

                13.2.4.4. Others

            13.2.5. Decongestant Sprays

                13.2.5.1. Phenylephrine Hydrochloride

                13.2.5.2. Oxymetazoline Hydrochloride

        13.3. Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

            13.3.1. Asthma

            13.3.2. Chronic Obstructive Pulmonary Disease (COPD)

            13.3.3. Allergic Rhinitis

            13.3.4. Others

        13.4. Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

            13.4.1. GCC Countries

            13.4.2. South Africa 

            13.4.3. Rest of Middle East & Africa

        13.5. North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

            13.5.1. By Drug Class

            13.5.2. By Indication

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by Tier and Size of companies)

        14.2. Market Share / Position Analysis, by Company, 2018

        14.3. Competitive Business Strategies

        14.4. Company Profiles

            14.4.1. Allergan plc.

                14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.1.2. Growth Strategies

                14.4.1.3. SWOT Analysis

            14.4.2. Beximco Pharmaceuticals Ltd 

                14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.2.2. Growth Strategies

                14.4.2.3. SWOT Analysis

            14.4.3. Cipla Limited

                14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.3.2. Growth Strategies

                14.4.3.3. SWOT Analysis

            14.4.4. Mylan N.V.

                14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.4.2. Growth Strategies

                14.4.4.3. SWOT Analysis

            14.4.5. Nephron Pharmaceuticals Corporation

                14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.5.2. Growth Strategies

                14.4.5.3. SWOT Analysis

            14.4.6. Sun Pharmaceutical Industries Ltd.

                14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.6.2. Growth Strategies

                14.4.6.3. SWOT Analysis 

            14.4.7. Hikma Pharmaceuticals PLC

                14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.7.2. Growth Strategies

                14.4.7.3. SWOT Analysis

            14.4.8. Sandoz International GmbH (a Novartis Division)

                14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.8.2. Growth Strategies

                14.4.8.3. SWOT Analysis

            14.4.9. Perrigo Company plc

                14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.9.2. Growth Strategies

                14.4.9.3. SWOT Analysis

            14.4.10. Teva Pharmaceutical Industries Ltd.

                14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.10.2. Growth Strategies

                14.4.10.3. SWOT Analysis

    List of Table

    Table 1 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

    Table 2 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

    Table 3 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

    Table 4 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

    Table 5 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

    Table 6 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

    Table 7 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 8 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 9 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

    Table 10 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

    Table 11 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

    Table 12 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

    Table 13 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

    Table 14 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

    Table 15 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 16 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

    Table 17 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

    Table 18 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

    Table 19 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

    Table 20 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

    Table 21 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

    Table 22 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 23 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

    Table 24 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

    Table 25 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

    Table 26 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

    Table 27 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

    Table 28 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

    Table 29 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 30 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

    Table 31 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

    Table 32 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

    Table 33 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

    Table 34 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

    Table 35 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

    Table 36 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 37 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

    Table 38 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

    Table 39 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

    Table 40 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

    Table 41 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

    Table 42 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

    List of Figure

    Figure 1 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

    Figure 2 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) and Forecast, 2019–2027

    Figure 3 Global Inhalation & Nasal Spray Generic Drugs Market Value Share (%), by Drug Class, 2018

    Figure 4 Global Inhalation & Nasal Spray Generic Drugs Market Value Share (%), by Indication, 2018

    Figure 5 Global Inhalation & Nasal Spray Generic Drugs Market Value Share (%), by Region, 2018

    Figure 6 Global Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

    Figure 7 Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

    Figure 8 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2017–2027

    Figure 9 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bronchodilators, 2017–2027

    Figure 10 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antihistamines, 2017–2027

    Figure 11 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Combinations, 2017–2027

    Figure 12 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Decongestant Sprays, 2017–2027

    Figure 13 Global Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

    Figure 14 Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

    Figure 15 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Asthma, 2017–2027

    Figure 16 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by COPD, 2017–2027

    Figure 17 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allergic Rhinits, 2017–2027

    Figure 18 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 19 Global Inhalation & Nasal Spray Generic Drugs Market Value Share, by Region, 2018 and 2027 

    Figure 20 Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Region, 2019–2027

    Figure 21 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 22 North America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country, 2018 and 2027

    Figure 23 North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country, 2019–2027

    Figure 24 North America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

    Figure 25 North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

    Figure 26 North America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

    Figure 27 North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

    Figure 28 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 29 Europe Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 30 Europe Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 31 Europe Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

    Figure 32 Europe Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

    Figure 33 Europe Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

    Figure 34 Europe Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

    Figure 35 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 36 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 37 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 38 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

    Figure 39 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

    Figure 40 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

    Figure 41 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

    Figure 42 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 43 Latin America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 44 Latin America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 45 Latin America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

    Figure 46 Latin America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

    Figure 47 Latin America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

    Figure 48 Latin America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

    Figure 49 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 50 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 51 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 52 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

    Figure 53 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

    Figure 54 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

    Figure 55 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

Copyright © Transparency Market Research, Inc. All Rights reserved

Inhalation and Nasal Spray Generic Drugs Market

Schedule a Call